Produs

Citicolin-BP (inj)

No image

Citicolin-BP (inj)

Injectable solution
Trade name
Citicolin-BP (inj)
Active ingridient
Citicolină
Descritpion and Composition
Citicolin-BP 125 mg/ml solution for injection: 1 ml contains citicoline 125 mg (as sodium salt, 130.63 mg); each 4 ml ampoule contains citicoline 500 mg. Citicolin-BP 250 mg/ml solution for injection: 1 ml contains citicoline 250 mg (as sodium salt, 261.26 mg); each 4 ml ampoule contains citicoline 1000 mg.

Indication: Acute cerebrovascular accident and its neurological sequelae. Traumatic brain injury and its neurological sequelae.

Contraindications (SmPC sec. 4.3): 4.3 Contraindications Hypersensitivity to citicoline or to any of the excipients listed in section 6.1. Patients with parasympathetic nervous system hypertonia.

Special warnings and precautions (SmPC sec. 4.4, excerpt): 4.4 Special warnings and precautions for use Intravenous administration must be given slowly (over 3 to 5 minutes, depending on the dose administered). When given by intravenous infusion, the drip rate should be 40-60 drops per minute. In the case of persistent intracranial haemorrhage, the dose of 1000 mg daily by very slow intravenous administration (30 drops per minute) must not be exceeded.
PIL